Last reviewed · How we verify

NCT05004779

Regenerative Effects of Human Stem Cell Media After Laser Therapy in Hypertrophic Scar

Status unknown NA Last updated 13 August 2021
What this trial tests

NA trial testing human stem cell conditioned media was applied after non-ablative laser therapy in Stem Cell Media in 30 participants. Status unknown.

Timeline
10 August 2021
Primary endpoint
31 December 2021
20 April 2022

Quick facts

Lead sponsorHangang Sacred Heart Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingsingle
Primary purposetreatment
Enrollment30
Start date10 August 2021
Primary completion31 December 2021
Estimated completion20 April 2022

Drugs / interventions tested

Conditions studied

Sponsor

Hangang Sacred Heart Hospital

Who can join

Adults 19 to 75, any sex, with Stem Cell Media or Hypertrophic Scar. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study was to determine the effect of combined treatment using nonablative laser and human stem cell media (HSCM) on the regeneration of hypertrophic scars that occurred after burns.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. The Potential of MSC-Based Cell-Free Therapy in Wound Healing-A Thorough Literature Review.
    Ma H, Siu WS, Leung PC. · · 2023 · cited 39× · PMID 37298306 · DOI 10.3390/ijms24119356
  2. Clinical Measurement of Transepidermal Water Loss.
    Kundu D, Jayaraman A, Sen CK. · · 2026 · cited 4× · PMID 40476522 · DOI 10.1089/wound.2024.0148

Verify or expand the search:

Other Hangang Sacred Heart Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05004779.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing